Lupin ventures into ophthalmology, spends €190 million for Dutch firm...
Mumbai: Pharma major Lupin has announced its entry into the ophthalmology market with the acquisition of Netherlands-based VISUfarma for €190 million (about Rs.1970 crores). This move is expected to help...
